1Hotta K, Funahashi T, Arita Y, et ah Plasma concentrations of a novel,adipose-specific protein, adiponectin, in type 2 diabetic patients[ J ]. Arterioscler Thromb Vasc Biol, 2000, 20 ( 6 ) : 1595-1599.
2Fasshauer M, Klein J, Neumann S, et al. Adiponectin gene expression is inhibited by beta-adrenergic stimulation via proteinkinase A in 3T3 1.1 adipocytes[J]. FEBS Lett,2001, 507(2) : 142-i46.
3Ouchi N, Kihara S, Arita Y, et ah Adipocyte derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages[J]. Circulation,2001,103(8) : 1057-1063.
4Jones BH, Standridge MK, Taylor JW, et al. Angiotensinogen gene expression in adipose tissue: analysis of obese models and hormonal and nutritional control[all. Am J Physiol, 1997,273 (1 Pt 2):R236 R242.
5Ouchi N, Kihara S, Arita Y, et al. Adiponectin, an adipoeyte- derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway[J]. Circulation, 2000,102(11) :1296 1301.
7O'Gara PT, Kushner FG, Ascheim DD. 2013 ACCF/AHA guideline for the management o: ST-elevation myocardial infarction[J]. Circulation,2013,127(4) : 362-425.
8Macdonald JE, Struthers AD. What is the optimal serum potassium level in cardiovascular patients? [J]. J Am Coil Cardiol, 2004,43 (2) .. 155-161.
9Telkova IL,Tepliakov AT, Karpov RS, et al. Possible role of hyperinsulinemia in pathogenesis of acute and chronic cardiac failure in patients with ischemic heart disease (data of clinical studies)[J] Kardiologiia, 2006,46 (6) : 43-48.
10Foo K, Cooper J, Deaner A, et al. A single serum glucose measurement predicts adverse outcomes across the whole range of acute coronary syndromes[J]. Heart, 2003,89 (5): 512-516.